<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32752182</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells-Focus on Immunological Pathways in Patients with ALS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1822</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells9081822</ELocationID><Abstract><AbstractText>Therapeutic interventions in amyotrophic lateral sclerosis (ALS) are still far from satisfying. Immune modulating procedures raise hopes for slowing the disease progression. Stem cell therapies are believed to possess the ability to regulate innate and adaptive immune response and inflammation processes. Hence, three intrathecal administrations of autologous bone marrow-derived lineage-negative (Lin<sup>-</sup>) cells were performed every six weeks in 40 sporadic ALS patients. The concentrations of inflammatory-related proteins and expression profiles of selected miRNA in the cerebrospinal fluid (CSF) and plasma at different timepoints post-transplantation were quantified by multiplex Luminex and qRT-PCR. The global gene expression in nucleated blood cells was assessed using the gene microarray technique. According to the ALS Functional Rating Scale (FRSr), the study population was divided into responders (group I, n = 17) and non-responders (group II, n = 23). A thorough analysis of the pro-inflammatory expression profiles, regulated miRNA pathways, and global gene expression profiles at the RNA level revealed the local and systemic effects of Lin<sup>-</sup> cell therapy on the immune system of patients with ALS. The autologous application of Lin<sup>-</sup> cells in CSF modulates immune processes and might prevent the progression of neurodegeneration. However, further in-depth studies are necessary to confirm the findings, and prolonged intervention is needed to maintain therapeutic effects.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baumert</LastName><ForeName>Bart&#x142;omiej</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-9933-5844</Identifier><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobu&#x15b;</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Go&#x142;&#x105;b-Janowska</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Pomeranian Medical University, 71-252 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paczkowska</LastName><ForeName>Edyta</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7052-9741</Identifier><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x141;uczkowska</LastName><ForeName>Karolina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4008-7473</Identifier><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogi&#x144;ska</LastName><ForeName>Dorota</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8884-837X</Identifier><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zawi&#x15b;lak</LastName><ForeName>Alicja</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2036-2853</Identifier><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milczarek</LastName><ForeName>S&#x142;awomir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Os&#x119;kowska</LastName><ForeName>Bogumi&#x142;a</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pawlukowska</LastName><ForeName>Wioletta</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Pomeranian Medical University, 71-252 Szczecin, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Rehabilitation and Clinical Physiotherapy, Pomeranian Medical University, 71-210 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meller</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Pomeranian Medical University, 71-252 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machowska-Sempruch</LastName><ForeName>Karolina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Pomeranian Medical University, 71-252 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>We&#x142;nicka</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Pomeranian Medical University, 71-252 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Safranow</LastName><ForeName>Krzysztof</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nowacki</LastName><ForeName>Przemys&#x142;aw</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Pomeranian Medical University, 71-252 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machali&#x144;ski</LastName><ForeName>Bogus&#x142;aw</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">gene microarrays</Keyword><Keyword MajorTopicYN="N">immunological pathways</Keyword><Keyword MajorTopicYN="N">inflammatory response</Keyword><Keyword MajorTopicYN="N">lineage-negative cells</Keyword><Keyword MajorTopicYN="N">miRNA</Keyword><Keyword MajorTopicYN="N">neurotrophins</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32752182</ArticleId><ArticleId IdType="pmc">PMC7463801</ArticleId><ArticleId IdType="doi">10.3390/cells9081822</ArticleId><ArticleId IdType="pii">cells9081822</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Amor S., Woodroofe M.N. Innate and adaptive immune responses in neurodegeneration and repair. Immunology. 2014;141:287&#x2013;291. doi: 10.1111/imm.12134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12134</ArticleId><ArticleId IdType="pmc">PMC3930367</ArticleId><ArticleId IdType="pubmed">23758741</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Berg L.H.V.D., Kiernan M.C. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2011;7:639&#x2013;649. doi: 10.1038/nrneurol.2011.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.153</ArticleId><ArticleId IdType="pubmed">21989247</ArticleId></ArticleIdList></Reference><Reference><Citation>Wobst H.J., Mack K.L., Brown D.G., Brandon N., Shorter J. The clinical trial landscape in amyotrophic lateral sclerosis&#x2014;Past, present, and future. Med. Res. Rev. 2020;40:1352&#x2013;1384. doi: 10.1002/med.21661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21661</ArticleId><ArticleId IdType="pmc">PMC7417284</ArticleId><ArticleId IdType="pubmed">32043626</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonafede R., Mariotti R. ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles. Front. Cell. Neurosci. 2017;11 doi: 10.3389/fncel.2017.00080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00080</ArticleId><ArticleId IdType="pmc">PMC5359305</ArticleId><ArticleId IdType="pubmed">28377696</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L., Ferrari D., Andjus P.R., Buzanska L., Cantello R., De Marchi F., Gelati M., Giniatullin R., Glover J.C., Grilli M., et al. Advances in stem cell therapy for amyotrophic lateral sclerosis. Expert Opin. Biol. Ther. 2018;18:865&#x2013;881. doi: 10.1080/14712598.2018.1503248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14712598.2018.1503248</ArticleId><ArticleId IdType="pubmed">30025485</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Cao C., Qin X.-Y., Yu Y., Yuan J., Zhao Y., Cheng Y. Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: A meta-analysis study. Sci. Rep. 2017;7:9094. doi: 10.1038/s41598-017-09097-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09097-1</ArticleId><ArticleId IdType="pmc">PMC5567306</ArticleId><ArticleId IdType="pubmed">28831083</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt J.I., Tajti J., Appel S.H. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch. Neurol. 1993;50:30&#x2013;36. doi: 10.1001/archneur.1993.00540010026013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1993.00540010026013</ArticleId><ArticleId IdType="pubmed">8093428</ArticleId></ArticleIdList></Reference><Reference><Citation>Graves M., Fiala M., Dinglasan L.A., Liu N., Sayre J., Chiappelli F., Van Kooten C., Vinters H. Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph. Lateral Scler. 2004;5:213&#x2013;219. doi: 10.1080/14660820410020286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820410020286</ArticleId><ArticleId IdType="pubmed">15799549</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnenfeld H., Kascsak R., Bartfeld H. Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients. J. Neuroimmunol. 1984;6:51&#x2013;57. doi: 10.1016/0165-5728(84)90042-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-5728(84)90042-0</ArticleId><ArticleId IdType="pubmed">6368581</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock B.J., Bender D.E., Kashlan S.R., Figueroa-Romero C., Backus C., Callaghan B.C., Goutman S.A., Feldman E. Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis. Neurol. Neuroimmunol. Neuroinflammation. 2016;3:e242. doi: 10.1212/NXI.0000000000000242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000242</ArticleId><ArticleId IdType="pmc">PMC4897983</ArticleId><ArticleId IdType="pubmed">27308304</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock B.J., Zhou T., Kashlan S.R., Little R.J., Goutman S.A., Feldman E.L. Correlation of Peripheral Immunity with Rapid Amyotrophic Lateral Sclerosis Progression. JAMA Neurol. 2017;74:1446&#x2013;1454. doi: 10.1001/jamaneurol.2017.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.2255</ArticleId><ArticleId IdType="pmc">PMC5822195</ArticleId><ArticleId IdType="pubmed">28973548</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunetta C., Lizio A., Maestri E., Sansone V.A., Mora G., Miller R.G., Appel S.H., Chi&#xf2; A. Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis. JAMA Neurol. 2017;74:660&#x2013;667. doi: 10.1001/jamaneurol.2016.6179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.6179</ArticleId><ArticleId IdType="pmc">PMC5822215</ArticleId><ArticleId IdType="pubmed">28384752</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereda C., Baiocchi C., Bongioanni P., Cova E., Guareschi S., Metelli M.R., Rossi B., Sbalsi I., Cuccia M.C., Ceroni M. TNF and sTNFR1/2 plasma levels in ALS patients. J. Neuroimmunol. 2008;194:123&#x2013;131. doi: 10.1016/j.jneuroim.2007.10.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2007.10.028</ArticleId><ArticleId IdType="pubmed">18083240</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon P.H., Moore D.H., Miller R.G., Florence J.M., Verheijde J.L., Doorish C., Hilton J.F., Spitalny G.M., MacArthur R.B., Mitsumoto H., et al. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: A phase III randomised trial. Lancet Neurol. 2007;6:1045&#x2013;1053. doi: 10.1016/S1474-4422(07)70270-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70270-3</ArticleId><ArticleId IdType="pubmed">17980667</ArticleId></ArticleIdList></Reference><Reference><Citation>Meucci N., Orazio E.N. Intravenous immunoglobulin therapy in amyotrophic lateral sclerosis. J. Neurol. 1996;243:117&#x2013;120. doi: 10.1007/BF02444000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02444000</ArticleId><ArticleId IdType="pubmed">8750546</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S.A., Miller R.G., Murphy J.R., Ringel S.P. Treatment of ALS with high dose pulse cyclophosphamide. J. Neurol. Sci. 1994;124:84&#x2013;87. doi: 10.1016/0022-510X(94)90188-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(94)90188-0</ArticleId><ArticleId IdType="pubmed">7807153</ArticleId></ArticleIdList></Reference><Reference><Citation>Joilin G., Leigh P.N., Newbury S.F., Hafezparast M. An Overview of MicroRNAs as Biomarkers of ALS. Front. Neurol. 2019;10:186. doi: 10.3389/fneur.2019.00186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00186</ArticleId><ArticleId IdType="pmc">PMC6416171</ArticleId><ArticleId IdType="pubmed">30899244</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Verrilli M., Caviedes A., Cabrera A., Sandoval S., Wyneken U., Khoury M. Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth. Neuroscience. 2016;320:129&#x2013;139. doi: 10.1016/j.neuroscience.2016.01.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2016.01.061</ArticleId><ArticleId IdType="pubmed">26851773</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.Y., Kim H., Oh K.-W., Oh S.-I., Koh S.-H., Baik W., Noh M.-Y., Kim K.S., Kim S.H. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: An investigator-initiated trial and in vivo study. Stem Cells. 2014;32:2724&#x2013;2731. doi: 10.1002/stem.1770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1770</ArticleId><ArticleId IdType="pubmed">24966156</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.H., Oh K.-W., Jin H.K., Bae J.-S. Immune inflammatory modulation as a potential therapeutic strategy of stem cell therapy for ALS and neurodegenerative diseases. BMB Rep. 2018;51:545&#x2013;546. doi: 10.5483/BMBRep.2018.51.11.255.</Citation><ArticleIdList><ArticleId IdType="doi">10.5483/BMBRep.2018.51.11.255</ArticleId><ArticleId IdType="pmc">PMC6283021</ArticleId><ArticleId IdType="pubmed">30463642</ArticleId></ArticleIdList></Reference><Reference><Citation>Forraz N., Pettengell R., McGuckin C. Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC. Stem Cells. 2004;22:100&#x2013;108. doi: 10.1634/stemcells.22-1-100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/stemcells.22-1-100</ArticleId><ArticleId IdType="pubmed">14688396</ArticleId></ArticleIdList></Reference><Reference><Citation>Machali&#x144;ska A., Rogi&#x144;ska D., Pius-Sadowska E., Kawa M.P., Paczkowska E., Rudnicki M., Lejkowska R., Baumert B., Barcew-Wiszniewska B., Machali&#x144;ski B. Neuroprotective and antiapoptotic activity of lineage-negative bone marrow cells after intravitreal injection in a mouse model of acute retinal injury. Stem Cells Int. 2015;2015:620364. doi: 10.1155/2015/620364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/620364</ArticleId><ArticleId IdType="pmc">PMC4354968</ArticleId><ArticleId IdType="pubmed">25810725</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobu&#x15b; A., Baumert B., Litwi&#x144;ska Z., Golab-Janowska M., St&#x119;pniewski J., Kotowski M., Pius-Sadowska E., Kawa M.P., Gr&#xf3;decka-Szwajkiewicz D., Peregud-Pogorzelski J., et al. Safety and Feasibility of Lin- Cells Administration to ALS Patients: A Novel View on Humoral Factors and miRNA Profiles. Int. J. Mol. Sci. 2018;19:1312. doi: 10.3390/ijms19051312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051312</ArticleId><ArticleId IdType="pmc">PMC5983708</ArticleId><ArticleId IdType="pubmed">29702606</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumert B., Sobu&#x15b; A., Golab-Janowska M., Litwi&#x144;ska Z., Paczkowska E., &#x141;uczkowska K., Zawi&#x15b;lak A., Milczarek S., Os&#x119;kowska B., Meller A., et al. Local and Systemic Humoral Response to Autologous Lineage-Negative Cells Intrathecal Administration in ALS Patients. Int. J. Mol. Sci. 2020;21:1070. doi: 10.3390/ijms21031070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21031070</ArticleId><ArticleId IdType="pmc">PMC7037134</ArticleId><ArticleId IdType="pubmed">32041109</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon P.H., Miller R.G., Moore D. ALSFRS-R. Amyotroph. Lateral Scler. 2004;5:90&#x2013;93. doi: 10.1080/17434470410019906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17434470410019906</ArticleId><ArticleId IdType="pubmed">15512883</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashizume A., Katsuno M., Suzuki K., Banno H., Suga N., Mano T., Araki A., Hijikata Y., Grunseich C., Kokkinis A., et al. A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study. Neuromuscul. Disord. 2015;25:554&#x2013;562. doi: 10.1016/j.nmd.2015.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2015.03.008</ArticleId><ArticleId IdType="pmc">PMC5608513</ArticleId><ArticleId IdType="pubmed">25913211</ArticleId></ArticleIdList></Reference><Reference><Citation>Paczkowska E., Kaczy&#x144;ska K., Pius-Sadowska E., Rogi&#x144;ska D., Kawa M., Ustianowski P., Safranow K., Celewicz Z., Machali&#x144;ski B. Humoral activity of cord blood-derived stem/progenitor cells: Implications for stem cell-based adjuvant therapy of neurodegenerative disorders. PLoS ONE. 2013;8:e83833. doi: 10.1371/journal.pone.0083833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083833</ArticleId><ArticleId IdType="pmc">PMC3877125</ArticleId><ArticleId IdType="pubmed">24391835</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Macklin E.A., Lee A., Murphy A., Chang J., Zipf A., Cudkowicz M., Atassi N. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS) Amyotroph. Lateral Scler. Front. Degener. 2014;15:453&#x2013;456. doi: 10.3109/21678421.2014.903974.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.903974</ArticleId><ArticleId IdType="pmc">PMC4433003</ArticleId><ArticleId IdType="pubmed">24981792</ArticleId></ArticleIdList></Reference><Reference><Citation>Toivonen J.M., Manzano R., Oliv&#xe1;n S., Zaragoza P., Garc&#xed;a-Redondo A., Osta R. MicroRNA-206: A potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS ONE. 2014;9:e89065. doi: 10.1371/journal.pone.0089065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0089065</ArticleId><ArticleId IdType="pmc">PMC3930686</ArticleId><ArticleId IdType="pubmed">24586506</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O., Jedrychowski M.P., Cialic R., Krasemann S., Murugaiyan G., Fanek Z., Greco D.J., Wu P.M., Doykan C.E., Kiner O., et al. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann. Neurol. 2014;77:75&#x2013;99. doi: 10.1002/ana.24304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24304</ArticleId><ArticleId IdType="pmc">PMC4432483</ArticleId><ArticleId IdType="pubmed">25381879</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci C., Marzocchi C., Battistini S. MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis. Cells. 2018;7:219. doi: 10.3390/cells7110219.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells7110219</ArticleId><ArticleId IdType="pmc">PMC6262636</ArticleId><ArticleId IdType="pubmed">30463376</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumert B., Przybycie&#x144; K., Paczkowska E., Kotowski M., Pius-Sadowska E., Safranow K., Peregud-Pogorzelski J., Kornacewicz-Jach Z., Peregud-Pogorzelska M., Machali&#x144;ski B. Novel Evidence of the Increase in Angiogenic Factor Plasma Levels after Lineage-Negative Stem/Progenitor Cell Intracoronary Infusion in Patients with Acute Myocardial Infarction. Int. J. Mol. Sci. 2019;20:3330. doi: 10.3390/ijms20133330.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20133330</ArticleId><ArticleId IdType="pmc">PMC6650859</ArticleId><ArticleId IdType="pubmed">31284593</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproston N.R., Ashworth J. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front. Immunol. 2018;9:754. doi: 10.3389/fimmu.2018.00754.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00754</ArticleId><ArticleId IdType="pmc">PMC5908901</ArticleId><ArticleId IdType="pubmed">29706967</ArticleId></ArticleIdList></Reference><Reference><Citation>Falvo J.V., Tsytsykova A.V., Goldfeld A.E. Transcriptional control of the TNF gene. Curr. Dir. Autoimmun. 2010;11:27&#x2013;60. doi: 10.1159/000289196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000289196</ArticleId><ArticleId IdType="pmc">PMC4785889</ArticleId><ArticleId IdType="pubmed">20173386</ArticleId></ArticleIdList></Reference><Reference><Citation>Botchkina G.I., Meistrell M.E., Botchkina I.L., Tracey K.J. Expression of TNF and TNF Receptors (p55 and p75) in the Rat Brain after Focal Cerebral Ischemia. Mol. Med. 1997;3:765&#x2013;781. doi: 10.1007/BF03401714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03401714</ArticleId><ArticleId IdType="pmc">PMC2230243</ArticleId><ArticleId IdType="pubmed">9407552</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G. TNF-R1 Signaling: A Beautiful Pathway. Science. 2002;296:1634&#x2013;1635. doi: 10.1126/science.1071924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1071924</ArticleId><ArticleId IdType="pubmed">12040173</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedger L., McDermott M.F. TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants &#x2013; past, present and future. Cytokine Growth Factor Rev. 2014;25:453&#x2013;472. doi: 10.1016/j.cytogfr.2014.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2014.07.016</ArticleId><ArticleId IdType="pubmed">25169849</ArticleId></ArticleIdList></Reference><Reference><Citation>Probert L., Akassoglou K., Pasparakis M., Kontogeorgos G., Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc. Natl. Acad. Sci. USA. 1995;92:11294&#x2013;11298. doi: 10.1073/pnas.92.24.11294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.24.11294</ArticleId><ArticleId IdType="pmc">PMC40618</ArticleId><ArticleId IdType="pubmed">7479982</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv S., Song H.-L., Zhou Y., Li L.-X., Cui W., Wang W., Liu P. Tumour necrosis factor-&#x3b1; affects blood-brain barrier permeability and tight junction-associated occludin in acute liver failure. Liver Int. 2010;30:1198&#x2013;1210. doi: 10.1111/j.1478-3231.2010.02211.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1478-3231.2010.02211.x</ArticleId><ArticleId IdType="pubmed">20492508</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel H.J., Patel B.M. TNF-&#x3b1; and cancer cachexia: Molecular insights and clinical implications. Life Sci. 2017;170:56&#x2013;63. doi: 10.1016/j.lfs.2016.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2016.11.033</ArticleId><ArticleId IdType="pubmed">27919820</ArticleId></ArticleIdList></Reference><Reference><Citation>Frankola K.A., Greig N.H., Luo W., Tweedie D. Targeting TNF-&#x3b1; to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS Neurol. Disord. Drug Targets. 2011;10:391&#x2013;403. doi: 10.2174/187152711794653751.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152711794653751</ArticleId><ArticleId IdType="pmc">PMC4663975</ArticleId><ArticleId IdType="pubmed">21288189</ArticleId></ArticleIdList></Reference><Reference><Citation>Taoufik E., Petit E., Divoux D., Tseveleki V., Mengozzi M., Roberts M.L., Valable S., Ghezzi P., Quackenbush J., Brines M.L., et al. TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury. Proc. Natl. Acad. Sci. USA. 2008;105:6185&#x2013;6190. doi: 10.1073/pnas.0801447105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0801447105</ArticleId><ArticleId IdType="pmc">PMC2299225</ArticleId><ArticleId IdType="pubmed">18413601</ArticleId></ArticleIdList></Reference><Reference><Citation>Brambilla L., Guidotti G., Martorana F., Iyer A., Aronica E., Valori C.F., Rossi D. Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2016;25:3080&#x2013;3095. doi: 10.1093/hmg/ddw161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw161</ArticleId><ArticleId IdType="pubmed">27288458</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Chen J., Sen S. MicroRNA as Biomarkers and Diagnostics. J. Cell. Physiol. 2015;231:25&#x2013;30. doi: 10.1002/jcp.25056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.25056</ArticleId><ArticleId IdType="pubmed">26031493</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilahi E., Adamecz Z., Bodoki L., Griger Z., P&#xf3;liska S., Nagy-Vincze M., Dank&#xf3; K. Dysregulated expression profile of myomiRs in the skeletal muscle of patients with polymyositis. EJIFCC. 2019;30:237&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6599196</ArticleId><ArticleId IdType="pubmed">31372109</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connell R.M., Chaudhuri A.A., Rao D.S., Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. USA. 2009;106:7113&#x2013;7118. doi: 10.1073/pnas.0902636106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0902636106</ArticleId><ArticleId IdType="pmc">PMC2678424</ArticleId><ArticleId IdType="pubmed">19359473</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Zhao Q., Matta R., Meng X., Liu X., Liu C.-G., Nelin L.D., Liu Y. Inducible Nitric-oxide Synthase Expression Is Regulated by Mitogen-activated Protein Kinase Phosphatase-1. J. Biol. Chem. 2009;284:27123&#x2013;27134. doi: 10.1074/jbc.M109.051235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.051235</ArticleId><ArticleId IdType="pmc">PMC2785641</ArticleId><ArticleId IdType="pubmed">19651781</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry R.J., Doran S.J., Barrett J.P., Meadows V.E., Sabirzhanov B., Stoica B., Loane D.J., Faden A. Inhibition of miR-155 Limits Neuroinflammation and Improves Functional Recovery After Experimental Traumatic Brain Injury in Mice. Neurotherapeutics. 2018;16:216&#x2013;230. doi: 10.1007/s13311-018-0665-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-018-0665-9</ArticleId><ArticleId IdType="pmc">PMC6361054</ArticleId><ArticleId IdType="pubmed">30225790</ArticleId></ArticleIdList></Reference><Reference><Citation>Koval E.D., Shaner C., Zhang P., Du Maine X., Fischer K., Tay J., Chau B.N., Wu G.F., Miller T.M. Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum. Mol. Genet. 2013;22:4127&#x2013;4135. doi: 10.1093/hmg/ddt261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt261</ArticleId><ArticleId IdType="pmc">PMC3781640</ArticleId><ArticleId IdType="pubmed">23740943</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerin I., Bommer G.T., McCoin C.S., Sousa K.M., Krishnan V., MacDougald O.A. Roles for miRNA-378/378* in adipocyte gene expression and lipogenesis. Am. J. Physiol. Metab. 2010;299:E198&#x2013;E206. doi: 10.1152/ajpendo.00179.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00179.2010</ArticleId><ArticleId IdType="pmc">PMC2928515</ArticleId><ArticleId IdType="pubmed">20484008</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulyt&#xe9; A., Lorente-Cebri&#xe1;n S., Gao H., Mejhert N., Agustsson T., Arner P., Ryden M., Dahlman I. MicroRNA profiling links miR-378 to enhanced adipocyte lipolysis in human cancer cachexia. Am. J. Physiol. Metab. 2014;306:E267&#x2013;E274. doi: 10.1152/ajpendo.00249.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00249.2013</ArticleId><ArticleId IdType="pubmed">24326420</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams A.H., Valdez G., Moresi V., Qi X., McAnally J., Elliott J.L., Bassel-Duby R., Sanes J.R., Olson E.N. MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in Mice. Science. 2009;326:1549&#x2013;1554. doi: 10.1126/science.1181046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Horak M., Novak J., Bienertov&#xe1;-Va&#x161;k&#x16f; J. Muscle-specific microRNAs in skeletal muscle development. Dev. Biol. 2016;410:1&#x2013;13. doi: 10.1016/j.ydbio.2015.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2015.12.013</ArticleId><ArticleId IdType="pubmed">26708096</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakasa T., Ishikawa M., Shi M., Shibuya H., Adachi N., Ochi M. Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model. J. Cell. Mol. Med. 2009;14:2495&#x2013;2505. doi: 10.1111/j.1582-4934.2009.00898.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1582-4934.2009.00898.x</ArticleId><ArticleId IdType="pmc">PMC3823166</ArticleId><ArticleId IdType="pubmed">19754672</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., King P.H., Si Y., Kwon Y., Varela V., Ibarburu S., Kovacs M., Moura I.C., Beckman J.S., Hermine O., et al. Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. JCI Insight. 2018;3 doi: 10.1172/jci.insight.123249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.123249</ArticleId><ArticleId IdType="pmc">PMC6237484</ArticleId><ArticleId IdType="pubmed">30282815</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Naujock M., Fumagalli L., Vandoorne T., Baatsen P., Boon R., Ordov&#xe1;s L., Patel A., Welters M., Vanwelden T., et al. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat. Commun. 2017;8:861. doi: 10.1038/s41467-017-00911-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00911-y</ArticleId><ArticleId IdType="pmc">PMC5636840</ArticleId><ArticleId IdType="pubmed">29021520</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Almeida S., Lu Y., Nishimura A.L., Peng L., Sun D., Wu B., Karydas A.M., Tartaglia M.C., Fong J.C., et al. Downregulation of MicroRNA-9 in iPSC-Derived Neurons of FTD/ALS Patients with TDP-43 Mutations. PLoS ONE. 2013;8:e76055. doi: 10.1371/journal.pone.0076055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0076055</ArticleId><ArticleId IdType="pmc">PMC3797144</ArticleId><ArticleId IdType="pubmed">24143176</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>